118
Participants
Start Date
July 1, 2019
Primary Completion Date
May 25, 2022
Study Completion Date
May 25, 2022
Tolvaptan
30mg and 15mg of Tolvaptan Tablet
Inje University Busan Paik Hospital, Busan
Kosin University Gospel Hospital, Busan
Hallym University Chuncheon Sacred Heart Hospital, Chuncheon
Keimyung University Dongsan Medical Center, Daegu
Kyungpook National University Hospital, Daegu
Chungnam National University Hospital, Daejeon
Chonnam National University Hospital, Gwangju
Gachon University Gil Medical Center, Incheon
Hallym University Medical Center, Pyeongchon
Seoul National University Bundang Hospital, Seongnam-si
Gangnam Severance Hospital, Seoul
Hallym University Kangnam Sacred Heart Hospital, Seoul
Hanyang University Seoul Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Severance Hospital, Seoul
SMG-SNU Boramae Medical Center, Seoul
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Seoul National University Hospital, Seoul
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
INDUSTRY